Characteristics | POD group (n = 35) | Non-POD group (n = 96) | aP value | effect size |
---|---|---|---|---|
Sex (n, male/female) | 15/20 | 39/57 | 0.818 | / |
Age (year) | 77(70 ~ 82) | 72(67 ~ 76) | 0.001 | 0.30 |
ASA status (I/II/III) | 2/22/11 | 8/73/15 | 0.169 | / |
BMI (kg/m2) | 21.88(19.58 ~ 25.40) | 23.50(22.04 ~ 26.38) | 0.058 | / |
Preoperative MMSE | 22(18 ~ 27) | 26(23 ~ 29) | 0.001 | 0.30 |
Medical comorbidities (n) | Â | Â | Â | Â |
 Hypertension | 29(82.86%) | 78(81.25%) | 0.833 | / |
 Diabetes mellitus | 13(37.14%) | 30(31.25%) | 0.525 | / |
 Coronary artery disease | 11(31.43%) | 27(28.13%) | 0.712 | / |
 History of stroke | 10(28.57%) | 19(19.79%) | 0.284 | / |
 Chronic pulmonary disease | 6(17.14%) | 16(16.67%) | 0.949 | / |
 Duration of surgery (min) | 85(75 ~ 95) | 80(70 ~ 90) | 0.454 | / |
 Blood loss(ml) | 250(200 ~ 300) | 250(200 ~ 350) | 0.815 | / |